COVID-19 Ozanimod Intervention Study
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology
- Status
- COMPLETED
- Phase
- N/A
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2
Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reduction Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant Nivolumab and Chemotherapy in Patients With Localized Triple-negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)
- Status
- RECRUITING
- Phase
- N/A
Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE2
CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart Failure
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Safety & Efficacy Belinostat Combo w Nivo Alone & w Ipi in Patients w Treated Metastatic/Advanced Carcinomas w ARID1A Lof Mutation
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types
- Status
- TERMINATED
- Phase
- PHASE1